1-1 of 1
potassium channel blockers
Close
Sort by
Journal Articles

Use of a Potassium Channel Blocker to Inhibit Effector-Memory T Cells Isolated from Recipients of Allogeneic BMSCT.

Cheryl Cameron, MD, Jeffrey Woodliff, Ph.D., Laura McOlash, Parameswaran Hari, MBBS, MD, MRCP, Christopher Bredeson, MD, David Margolis, MD, Robert L. Truitt, PhD
Journal: Blood
Blood (2008) 112 (11): 1154.
https://doi.org/10.1182/blood.V112.11.1154.1154
Published: 2008